智度股份(000676.SZ):與廣州三七互娛簽署戰略合作框架協議 欲打造全國領先的三七互娛元宇宙展館
格隆匯4月15日丨智度股份(000676.SZ)公佈,公司及控股子公司廣州智度宇宙技術有限公司(簡稱“智度宇宙”)於2022年4月15日與廣州三七互娛科技有限公司(簡稱“廣州三七互娛”)簽署了《智度元宇宙戰略合作框架協議書》。
各方本着“優勢互補、合作共贏”的原則,充分發揮公司及智度宇宙的科技、創新、數字營銷及生態資源優勢,以及三七互娛的知名遊戲IP、工藝美術、遊戲模型等資源優勢,共同推動新一代元宇宙技術與遊戲經濟深度融合,在智度宇宙的國內首家元宇宙藝術社區“Meta彼岸”中落地“互聯網+”行動計劃,打造全國領先的“三七互娛”元宇宙展館。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.